Managing Directors


Mr. Eastman has over 30 years of experience in building healthcare businesses. He began his career at American Cyanamid Company which was acquired by American Home Products (now Wyeth). At Cyanamid, Mr. Eastman spent 15 years managing various pharmaceutical products, divisions and subsidiaries in the U.S. and overseas. Since then he has helped build three private healthcare companies. Under his leadership, Geron became a cutting edge biotech company that grew from a venture-backed startup to a publicly traded pioneer in the fields of regenerative medicine and cancer. HCORP quickly established itself as the technology and market leader in the emerging field of hospital-based, interactive patient services and was sold to a diversified competitor. Most recently, at
Rinat Neuroscience, a private biotech company spun out of Genentech in late 2001, Mr. Eastman led the effort to recruit an experienced management team and move Rinat’s first product for the treatment of pain into clinical trials. Rinat was recently acquired by Pfizer in 2006.

Mr. Eastman has served on the Board of BIO, the biotechnology trade organization, and currently serves as a trustee at The Buck Institute, the largest non-profit research institute in the U.S. studying diseases of aging. He serves as the Chairman of the Board at Elusys Therapeutics and on the Board of Directors for Corium International
and OMT. Mr. Eastman earned his B.A. from Williams College and his M.B.A. from Columbia University.
 
   
  MANAGING DIRECTORS 
 
James Currie
 
Ron Eastman
 
Jeff Himawan, PhD
 Guido Neels
 
Mark Pacala
 
Martin Sutter
 
Immanuel Thangaraj 
 
Petri Vainio, MD, PhD
 Steve Wiggins

SENIOR ADVISORS
PARTNERS
ADJUNCT PARTNERS
PRINCIPALS

 

 



 

 
  © 2008 Essex Woodlands Health Ventures  |  All Rights Reserved  |  Legal Disclaimer